Growth Metrics

Novartis Ag (NVS) Receivables - Net (2016 - 2025)

Novartis Ag's Receivables - Net history spans 14 years, with the latest figure at $8.9 billion for Q4 2025.

  • On a quarterly basis, Receivables - Net rose 20.4% to $8.9 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $8.9 billion, a 20.4% increase, with the full-year FY2025 number at $8.9 billion, up 20.4% from a year prior.
  • Receivables - Net hit $8.9 billion in Q4 2025 for Novartis Ag, down from $9.1 billion in the prior quarter.
  • Over the last five years, Receivables - Net for NVS hit a ceiling of $9.2 billion in Q2 2023 and a floor of $7.1 billion in Q4 2023.
  • Historically, Receivables - Net has averaged $8.3 billion across 5 years, with a median of $8.3 billion in 2021.
  • Biggest five-year swings in Receivables - Net: fell 11.89% in 2023 and later rose 20.4% in 2025.
  • Tracing NVS's Receivables - Net over 5 years: stood at $8.0 billion in 2021, then increased by 0.76% to $8.1 billion in 2022, then dropped by 11.89% to $7.1 billion in 2023, then rose by 4.45% to $7.4 billion in 2024, then rose by 20.4% to $8.9 billion in 2025.
  • Business Quant data shows Receivables - Net for NVS at $8.9 billion in Q4 2025, $9.1 billion in Q2 2025, and $7.4 billion in Q4 2024.